Randomized, double-blind, placebo-controlled trial of the immune modulator WF10 in patients with advanced AIDS

Infection

Volumn 26, Issue 4, 1998, Pages 202-207

  Raffanti, S P ^a,b   Schaffner, W ^a,b   Federspiel, C F ^a   Blackwell, R B ^b   Ching, O A ^c   Kuhne F W ^c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b A 1124 MCN ^*  (United States)

^c OXO Chemie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD16 ANTIGEN; CD19 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; INTERLEUKIN 2 RECEPTOR; TETRACHLORODECAOXIDE; UNCLASSIFIED DRUG; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS RELATED COMPLEX; ARTICLE; BLOOD CHEMISTRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; FOLLOW UP; HEMATOLOGY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOMODULATION; INJECTION SITE; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROPHAGE FUNCTION; MALE; MONOCYTE; MORTALITY; NEUTROPHIL; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL;

EID: 0031866765     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02962364     Document Type: Article

References (24)

1. Kühne, F. W.: Die erwünschte Sauerstoffaktivierung, dokumentiert am Beispiel der Wundheilung: der Weg zur Oxoferin-Therapie. In: Elstner E. F., Bors W., Wilmanns W. (eds.): Reaktive Sauerstoffspezies in der Medizin. Springer Verlag. Berlin 1986. pp. 5-15.
2. Ullmann, U., Kühne, F. W.: In vitro investigations on the antibacterial action and the influence on the phagocytic chemiluminescence of tetrachlordecaoxide - a new non-metallic oxygen complex. Infection 12 (1984) 225-229.
3. Woerly, G., Lombard, Y., Poindron, P., Stahl, K. W.: Candida phagocytosis of murine macrophages: enhancement by a novel type of oxidant. In: Mauri C., Rizzo S. C., Ricevuti G. (eds.): The biology of phagocytosis in health and disease. Pergamon Press. Oxford 1987, pp. 109-112.
4. Ennen, J., Werner, K., Kühne, F. W., Kurth, R.: Inactivation of HIV infectivity by the chlorite-oxygen reaction product tetrachlordecaoxygen. AIDS 7 (1993) 1205-1212.
5. Gillissen, G., Kühne, F. W., Breuer-Werle, M., Melzer, B., Ostendorp H.: Increased resistance towards two systemic experimental infections by tetrachlorodecaoxygen anion complex. Arzneimittelforschung/Drug Research 36 (1986) 1778-1782.
6. Hänsel, M., Poindron, P., Stahl, K. W.: Modulation of leucocyte growth in intraepidermal skin blisters. Skin Pharmacol. 1 (1988) 64.
7. Müller-Klieser, W., Vaupel, P.: Improvement of tumour-spheroid oxygenation by tetrachlorodecaoxygen. Int. J. Radiat. Oncol. Biol. Phys. 13 (1987) 49-54.
8. Ivankovic, S., Kempf, S. R.: Regenerative effects of tetrachlorodecaoxide in BD IX rats after total-body δ-irradiation. Radiat. Res. 115 (1988) 115-123.
9. Breiter, N., Sassy, T., Trott, K. R.: Tetrachlorodecaoxygen anion complex treatment after localised x irradiation of the rat colon. Br. J. Radiol. 62 (1989) 381-383.
10. Milas, L.: Therapeutic potential of using radioprotective agents for minimising radiation injury of normal tissue. Presented at the International Symposium on Tissue Repair. 7 December 1990, Pattaya, Thailand.
11. Mason, K. A., Murphy, S., Milas, L.: Stimulation of hematopoietic cell recovery by tetrachlordecaoxide in sublethally irradiated mice. Radiat. Res. 136 (1993) 229-235.
12. Günther, H.-J., Hinz, J.: Die Beeinflussung von Wundheilungsstörungen und Wundinfektionen mit Oxoferin. Ergebnisse einer Phase IV Studie in der Klinik. In: Macher, E., Knop, J., Brocker, E. B. (eds.): Jahrbuch der Dermatologie 1989/1990. Biermann Verlag, Münster 1990, pp. 141-148.
13. Teepe, R. G. C., Koebrugge, E. J., Löwik, C. W. G. M., Petit, P. L. C., Bosboom, R. W., Twiss, I. M., Boxma, H., Vermeer, B. J., Ponec, M.: Cytotoxic effects of antimicrobial and antiseptic agents on human keratinocytes in vitro. J. Trauma 35 (1993) 8-19.
14. Crowe, S. M.: Role of macrophages in the pathogenesis of human immunodeficiency virus (HIV) infection. Aust. N Z J Med. 25 (1995) 777-783.
15. Kühne, F. W.: A new anti-HIV agent combining immunomodulation with antiretroviral activity, Presented at the 4th Annual Houston Conference on AIDS in America, 20 March 1992. Houston. Texas.
16. Bodin, L., Tansuphaswadikul, S., Kühne, F. W., Rungsiwongse, J., Likanosakul, S., Eampokalap, B.: Preliminary evaluation of the efficacy and tolerance of WF10 (TCDO) i.v. solution as adjunctive therapy in the management of adult patients with symptomatic human immunodeficiency virus infection. Presented at the 2nd National Conference on AIDS. 21 May 1992. Jomtien-Pattaya, Thailand.
17. Busch, H. W., Christensen, S., Reichelt, D., Jahn, S., Zidek, W.: Treatment of HIV-infected patients with advanced symptomatic disease with WF10 solution (TCDO). Poster presented at the 10th International Conference on AIDS, 7-12 August 1994. Yokahama. Japan.
18. Somsit, T.: Long-term safety and efficacy of WF10 (TCDO) i.v. solution as adjunctive therapy in the management of adult patients with symptomatic human immunodeficiency virus infection. Presented at the International Workshop on Immunomodulation: a new approach to the promotion of immune functions in health and diseases. 17 May 1997, Hua Hin. Thailand.
19. 2) with equimolar chlorite content on bone marrow and peripheral blood of BDIX rats. Drugs Exp. Clin. Res. 19 (1993) 165-174.
20. Hatz, R. A., Kelley, S. F., Ehrlich, H. P.: The tetrachlorodecaoxygen complex reverses the effect of cortisone on wound healing. Plast. Reconstr. Surg. 84 (1989) 952-959.
21. Hinz, H., Hautzinger, H., Stahl, K. W.: Rationale for and results from a randomised double-blind trial of tetrachlorodecaoxygen anion complex in Wound healing. Lancet i (1986) 825-828.
22. Koyanagi, Y., O'Brien, W. A., Zhao, J. Q., Golde, D. W., Gasson, J. C., Chen, I. S. Y.: Cytokines alter production of HIV-1 from primary mononuciear phagocytes. Science 241 (1988) 1673-1675.
23. Kaplan, I., D., Kahn, J. O., Crowe, S., Northfelt, D., Neville, P., Grossberg, H., Abrams, D. I., Tracey, J., Mills, J., Volberding, P. A.: Clinical and virologic effects of recombinant human granulocytemacrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. J. Clin. Oncol. 9 (1991) 929-940.
24. Weissman, D., Fauci, A. S.: Role of dendritic cells in immunopathogenesis of human immunodeficiency virus infection. Clin. Microbiol. Rev. 10 (1997) 358-367.